Canopy Growth CGC
NASDAQ CGC
$1.03 -0.01 (-1.12%)
At close: Aug 20, 2026 · 11:01 AM UTC

Canopy Growth (CGC) Interest & Investment Income (2019 - 2026)

Canopy Growth (CGC) posted Interest & Investment Income of $4.4 million for Q4 2025, up 206.3% sequentially from $1.4 million in Q3 2025, and up 216.52% YoY from $1.4 million in Q4 2024.

Canopy Growth (CGC) Interest & Investment Income (2019 - 2026) Analysis & Trends

Canopy Growth has reported Interest & Investment Income for 7 years, with the latest figure at $4.4 million in Q4 2025.

  • Quarterly Interest & Investment Income rose 216.52% year-over-year to $4.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $8.0 million (up 23.86% YoY) and the FY2026 annual result came in at $7.3 million, up 18.66% from the prior year.
  • Interest & Investment Income grew to $4.4 million in Q4 2025 per CGC's latest filing, from $1.4 million in the prior quarter.
  • Over five years, Interest & Investment Income peaked at $6.2 million in Q1 2023 and troughed at -$296842.8 in Q1 2022.
  • A 5-year average of $2.6 million and a median of $1.9 million in 2023 frame the typical range for Interest & Investment Income.
  • The sharpest annual moves came in 2022 and 2023: Interest & Investment Income plunged 116.41% in 2022, then jumped 2183.21% in 2023.
  • Over 5 years, Interest & Investment Income stood at $1.2 million in 2021, then soared by 315.55% to $5.2 million in 2022, then tumbled by 63.95% to $1.9 million in 2023, then fell by 25.76% to $1.4 million in 2024, then soared by 216.52% to $4.4 million in 2025.
  • According to Business Quant data, Interest & Investment Income over the past three periods registered $4.4 million, $1.4 million, and $762850.1 for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Haleon 43.81 Bn 42.84 Bn - -
2 Teva Pharmaceutical Industries 43.29 Bn 39.63 Bn 2.15 Bn -
3 Zoetis 31.59 Bn 29.91 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.67 Bn 22.88 Bn 5.10 Bn 154.39 Mn
5 United Therapeutics 22.24 Bn 19.58 Bn 683.80 Mn 31.50 Mn
6 Viatris 18.79 Bn 17.91 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.71 Bn 15.32 Bn 935.80 Mn 12.40 Mn
8 Elanco Animal Health 12.09 Bn 11.56 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.11 Bn 9.95 Bn - -
10 Canopy Growth 434.93 Mn 187.92 Mn 16.08 Mn 2.34 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 2.34 Mn
Dec 31, 2025 4.40 Mn
Sep 30, 2025 1.44 Mn
Jun 30, 2025 762,850.11
Dec 31, 2024 1.39 Mn
Sep 30, 2024 1.77 Mn
Jun 30, 2024 1.50 Mn
Mar 31, 2024 1.78 Mn
Dec 31, 2023 1.87 Mn
Sep 30, 2023 2.58 Mn
Jun 30, 2023 5.83 Mn
Mar 31, 2023 6.18 Mn
Dec 31, 2022 5.19 Mn
Sep 30, 2022 3.78 Mn
Jun 30, 2022 3.10 Mn
Mar 31, 2022 -296,842.75
Dec 31, 2021 1.25 Mn
Sep 30, 2021 2.19 Mn
Jun 30, 2021 2.15 Mn
Mar 31, 2021 1.81 Mn